北美脑部 MRI 扫描市场，按扫描仪类型（低场强（MRI 机器）、脑部疾病类型（脑肿瘤、痴呆、阿尔茨海默病、帕金森病、癫痫和癫痫发作、中风、多发性硬化症等）、最终用户（医院、影像和诊断中心、门诊手术中心等）、分销渠道（直接招标、零售销售）、行业趋势和预测到 2029 年
市场分析和透视:北美脑磁共振扫描市场
脑磁共振扫描是一种罕见的神经病症,儿童大脑在怀孕期间发育不当. 由于妊娠12至24周间发生的神经外移失败而发展而来,导致正常的脑陀螺和sulci发育缺失. 胃口切除管被插入到儿童胃中,因为进食和吞咽困难. 根据研究,它可能由多基因的故障所引起. 多数这些基因的改变并不总是从父母那里继承的. 在没有病史时,他们可以随机出现在一个人的基因化妆中.
北美脑磁共振扫描是支持性的,旨在降低症状的严重程度. 数据桥市场研究(Data Bridge Market Research)分析认为,脑磁共振扫描市场将在2022至2029年的预测期以5.1%的CAGR增长.
|
报表计量 |
细节 |
|
预测期 |
2022至2029年统计 |
|
基准年 |
2021 |
|
历史年代 |
2020年(2019-2014年可定制). |
|
数量单位 |
收入(百万美元),定价(美元) |
|
覆盖部分 |
通过扫描器类型(低地强力(<1.5t磁共振)、中地强力(1.5t磁共振至3.0t磁共振和高地强力(4t和以上))),机器类型(开放磁共振机、闭合磁共振机和立体或坐地磁共振机.),脑功能障碍类型(脑肿瘤、痴呆症、老年痴呆症、帕金森病、癫痫和癫痫、斯特罗克、多发作等),终端用户(医院、成形和诊断中心、门诊外科中心等),分发渠道(发酵、零售销售) |
|
涵盖国家 |
美国、加拿大和墨西哥 |
|
覆盖的市场玩家 |
Koninklijke Philips N.V. 通用电气公司,FUJIFILM 控股美国公司,西门子医疗股份有限公司,CANON Medical Systems CORPOLINC,ESAOTE SPA,Hyperfine,Time Medical Holding.,深圳安克高科技股份有限公司,联合IMAGING,SternMed GmbH.,北京万东医疗技术股份有限公司,BASDA,Ultravis医疗设备贸易有限公司,Neusoft Corporation,Eleekta AB,全科技医疗系统美国,FONAR公司,Bruker,显像有限公司,ASG超级导体SPA,Minfund医疗系统有限公司和突触医疗系统公司 |
脑磁共振扫描市场动态
司机
- 慢性神经疾病的发病率和发病率上升
中风和痴呆等神经病发病率的上升将增加脑磁共振扫描设备的诊断和使用,从而成为市场增长率扩大的主要驱动力。
比如说,
- 2021年,家庭护理者联盟的数据显示,美国有60多万人被诊断出中风,25万人被诊断出阿尔茨海默症. 在美国,每年有120万18岁及以上的人被诊断患有成人发作性脑病.
- 产品批准量的上升
影响脑磁共振扫描市场增长率的另一个重要因素是对使用脑磁共振扫描的核准,这有助于改进其基础设施。
- 中场强度磁共振装置技术发展的增长
另外,中场强度核磁共振装置,如人工智能和超声波等技术开发的增长会进一步增强脑磁共振扫描市场的成长.
此外,医疗技术的进步、公共和私营组织为提高认识而提出的越来越多的倡议以及政府资金的增加,是扩大雨磁共振扫描市场的因素。 其他因素,如对有效疗法的需求增加和对及时诊断的认识提高,并将对脑磁共振扫描市场的增长率产生积极影响。 此外,可支配收入高,艾滋病毒/艾滋病病例增加。缉获量改变生活方式将导致脑磁共振扫描市场的扩大。
机会
- 保健开支的增加
此外,研究和发展活动的增加以及政府和私营组织投资的增加将增加市场增长率的新机会。
此外,启动有效的疗法和持续临床试验将为2022-2029年预测期的脑磁共振扫描市场提供有益机会。 此外,保健技术的当前需要和发展情况得不到满足,今后脑磁共振扫描市场的增长率将升级。
限制/挑战
然而,与低收入国家现有和缺乏基础设施有关的高成本会阻碍脑磁共振扫描市场的增长率。 此外,在使用核磁共振装置时产生的风险会阻碍脑磁共振扫描市场增长。 缺乏这种神经病的治疗方法以及对遗传和罕见疾病的认识会进一步挑战上述预测期的市场。
脑磁共振扫描市场报告提供近期新发展,贸易监管,进出口分析,生产分析,价值链优化,市场份额,国内和本地化市场主体的影响等详细信息,分析新兴收入口号,市场监管变化,战略性市场增长分析,市场规模,类别市场增长,应用优势和支配地位,产品审批,产品发布,地域扩张,市场技术创新等方面的机会. 获取更多关于脑磁共振扫描市场联系人的信息 数据桥市场研究分析员简介我们的团队会帮助你做出明智的市场决定 实现市场增长
患者流行病学分析
脑磁共振扫描是一种脑部紊乱症,相对来说是罕见的,其发病率也不明. 家庭护理者联盟的一项研究指出,约有25万人确诊患有老年痴呆症。
脑磁共振扫描市场也为您提供了详细的市场分析,用于患者分析,预后和治愈. 流行率、发生率、死亡率、坚持率是报告中现有的一些数据变量。 对流行病学对市场增长的直接或间接影响分析进行了分析,为预测增长时期的市场创造了一种更有力和组合的多变统计模型。
影响脑磁共振扫描市场
COVID-19对市场产生了负面影响. 流行病期间的封锁和隔离使诊断管理和治疗复杂化。 无法利用保健设施进行日常和药品管理,将进一步影响市场。 社会孤立增加了压力、绝望和社会支持,所有这些都可能导致在大流行病期间抗惊厥药物的坚持率下降。
最近的发展
- 2020年12月,在疫情期间,BASDA在中国推出了无液氦1.5t超导核磁共振扫描仪. 产品发射改善了超导磁共振部分的产品范围。 它将使1.5t超导核磁共振扫描仪在中国的成像和诊断中心得到。 预计将增加收入。
北美脑磁共振扫描市场范围
脑磁共振扫描市场根据扫描器类型,机器类型,脑部紊乱,终端用户和发行渠道进行分块. 这些部门的增长将有助于你分析这些行业中增长不足的部分,并为用户提供宝贵的市场概况和市场见解,帮助他们作出确定核心市场应用的战略决定。
扫描机类型
- 低场强度(<1.5T磁共振)
- 中场强度(1.5T磁共振到3.0T磁共振)
- 高战地强度(4T和以上)
基于扫描器类型,中场强度被分解为低场强度(<1.5T核磁共振),中场强度(1.5T核磁共振到3.0T核磁共振)和高场强度(4T及以上).
机器类型
- 打开 MRI 机
- 关闭的核磁共振机
- 站立或坐立磁共振机
根据机型,北美脑磁共振扫描市场被分出为开口磁共振机,闭口磁共振机和站立或坐立磁共振机.
脑疾病
- 脑肿瘤
- 痴呆症
- 阿尔茨海默病
- 帕金森疾病
- 癫痫和扣押
- 键
- 多重硬化症
- 其别者.
北美脑磁共振扫描市场 被分解成脑瘤 痴呆症阿尔茨海默症帕金森的疾病,癫痫以及癫痫、中风、多发性硬化等。
结束用户
- 医院
- 成像和诊断中心
- 门诊外科中心
- 其他人员
在最终用户的基础上,北美脑磁共振扫描市场分为医院、成像和诊断中心、流动外科中心等。
分发频道
- 直接招标
- 零售
在发售渠道的基础上,北美脑磁共振扫描市场被分割成直接招标,零售.
管道分析(未提供)
脑磁共振扫描市场国家分析/见解
对北美脑磁共振扫描市场进行了分析,并按国家、扫描器类型、机器类型、脑病、最终用户和分销渠道提供了市场大小的见解和趋势。 见上文。
脑磁共振扫描市场报告中涵盖的国家是北美的美国、加拿大和墨西哥。
美国在市场份额和市场收入方面主导了脑磁共振扫描市场,并将在预测期间继续繁荣其主导地位. 这是由于该地区主要行为者和完善的保健基础设施的存在以及先进的核磁共振扫描设备的提供。
报告的国家部分还介绍了影响市场的因素和国内市场规章的变化,这些变化影响到市场目前和未来的趋势。 新的销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用来预测个别国家市场情况的一些主要指针。 此外,北美品牌的存在和可得性以及它们由于来自当地和国内品牌的大规模或稀缺竞争而面临的挑战,也考虑了销售渠道的影响,同时对国家数据进行预测分析。
竞争性景观和脑磁共振扫描市场 共享分析
北美脑磁共振扫描市场竞争景观 提供细节 通过竞争者。 详细情况包括公司概况、公司财务、创收、市场潜力、研发投资、新市场举措、北美的存在、生产地点和设施、生产能力、公司优缺点、产品推出、产品宽度和广度、应用优势。 上述数据点仅与公司与脑磁共振扫描市场相关的重点有关.
在大脑核磁共振扫描市场运营的一些主要玩家有Koninklijke Philips N.V.通用电气公司,FUJIFILM. 控股美国公司,西门子保健股份有限公司,CANON Medical Systems CORPOLINC,ESAOTE SPA,Hyperfine,Time Medical Holding.,深圳安克高科技股份有限公司,联合IMAGING,斯特恩美德股份有限公司,北京万东医疗技术股份有限公司,BASDA,Ultravis医疗设备贸易有限公司,Neusoft公司,Elekta AB,全科技医疗系统美国,FONAR公司,Bruker,显像有限公司,ASG超级导体SPA,Minfund医疗系统有限公司等.
SKU-
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA BRAIN MRI SCAN MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 NORTH AMERICA BRAIN MRI SCAN MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
4.3 NUMER OF PATIENTS GETTING PERIODIC HEALTH EXAMINATIONS (PHE) USING MRI
5 NORTH AMERICA BRAIN MRI SCAN MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISORDERS
6.1.2 AWARENESS AMONG POPULATION ABOUT THE TREATMENT AND USE OF BRAIN SCAN MRIDEVICES
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN BRAIN MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES
6.1.4 FAVORABLE REIMBURSEMENT POLICIES
6.1.5 RISE IN PRODUCT APPROVALS
6.2 RESTRAINTS
6.2.1 RISE IN COST OF THE MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES
6.2.2 RISKS NOTICED WHILE USING MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES
6.2.3 RISE IN PRODUCT RECALL
6.2.4 AVAILABILITY OF ALTERNATE IMAGING DIAGNOSTIC DEVICES
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.2 RISE IN HEALTHCARE EXPENDITURE
6.3.3 INCREASE IN DEMAND FOR NON-INVASIVE MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS REQUIRED FOR USE OF BRAIN MRI SCAN DEVICES
6.4.2 STRINGENT REGULATIONS
7 NORTH AMERICA BRAIN MRI SCAN MARKET, BY SCANNER TYPE
7.1 OVERVIEW
7.2 MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI)
7.2.1 FIELD STRENGTH 1.5T
7.2.2 FIELD STRENGTH 3T
7.3 LOW FIELD STRENGTH (<1.5T MRI)
7.4 HIGH FIELD STRENGTH (4T AND ABOVE)
8 NORTH AMERICA BRAIN MRI SCAN MARKET, BY MACHINE TYPE
8.1 OVERVIEW
8.2 CLOSED MRI MACHINE
8.3 OPEN MRI MACHINE
8.4 STANDING OR SITTING MRI MACHINE
9 NORTH AMERICA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER
9.1 OVERVIEW
9.2 DEMENTIA
9.2.1 BY MACHINE TYPE
9.2.1.1 CLOSED MRI MACHINE
9.2.1.2 OPEN MRI MACHINE
9.2.1.3 STANDING OR SITTING MRI MACHINE
9.3 ALZHEIMER'S DISEASE
9.3.1 BY MACHINE TYPE
9.3.1.1 CLOSED MRI MACHINE
9.3.1.2 OPEN MRI MACHINE
9.3.1.3 STANDING OR SITTING MRI MACHINE
9.4 EPILEPSY AND SEIZURE
9.4.1 BY MACHINE TYPE
9.4.1.1 CLOSED MRI MACHINE
9.4.1.2 OPEN MRI MACHINE
9.4.1.3 STANDING OR SITTING MRI MACHINE
9.5 PARKINSON'S DISEASE
9.5.1 BY MACHINE TYPE
9.5.1.1 CLOSED MRI MACHINE
9.5.1.2 OPEN MRI MACHINE
9.5.1.3 STANDING OR SITTING MRI MACHINE
9.6 STROKE
9.6.1 BY MACHINE TYPE
9.6.1.1 CLOSED MRI MACHINE
9.6.1.2 OPEN MRI MACHINE
9.6.1.3 STANDING OR SITTING MRI MACHINE
9.7 MULTIPLE SCLEROSIS
9.7.1 BY MACHINE TYPE
9.7.1.1 CLOSED MRI MACHINE
9.7.1.2 OPEN MRI MACHINE
9.7.1.3 STANDING OR SITTING MRI MACHINE
9.8 BRAIN TUMOR
9.8.1 BY MACHINE TYPE
9.8.1.1 CLOSED MRI MACHINE
9.8.1.2 OPEN MRI MACHINE
9.8.1.3 STANDING OR SITTING MRI MACHINE
9.9 OTHER BRAIN DISORDERS
10 NORTH AMERICA BRAIN MRI SCAN MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 IMAGING DIAGNOSTIC CENTERS
10.4 AMBULATORY SURGERY CENTERS
10.5 OTHERS
11 NORTH AMERICA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
12 NORTH AMERICA BRAIN MRI SCAN MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA BRAIN MRI SCAN MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 SIEMENS AG
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.1.5.1 ACQUISITION
15.2 GENERAL ELECTRIC COMPANY
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.2.5.1 PRODUCT APPROVAL
15.3 CANON MEDICAL SYSTEMS CORPORATION (A SUBSIDIARY OF CANON INC.)
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 KONINKLIJKE PHILIPS N.V
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 FUJIFILM HOLDINGS AMERICA CORPORATION (2021)
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ELEKTA AB
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUS ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 ALLTECH MEDICAL SYSTEMS
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 ASPECT IMAGING
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 ASG SUPERCONDUCTORS SPA
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BRUKER (2021)
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 BASDA
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD (2021)
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 ESAOTE SPA
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.13.3.1 PRODUCT APPROVAL
15.14 FONAR CORP.
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUS ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENT
15.15 HYPERFINE
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 MINFOUND MEDICAL SYSTEMS CO.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 MEDONICA CO. LTD
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 NEUSOFT MEDICAL SYSTEMS
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 STEMLAB, INC.
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 STERNMED GMBH
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 SYNAPTIVE MEDICAL
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
15.22 SHENZHEN ANKE HIGH-TECH CO., LTD.
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENT
15.23 TIME MEDICAL HOLDING
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 VOXELGRIDS
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 UNITED IMAGING
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENT
15.26 ULTRAVISION MEDICAL EQUIPMENT TRADING L.L.C
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 2 NORTH AMERICA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA LOW FIELD STRENGTH (<1.5T MRI) IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA HIGH FIELD STRENGTH (4T AND ABOVE) IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA CLOSED MRI MACHINE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA OPEN MRI MACHINE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA STANDING OR SITTING MRI MACHINE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA DEMENTIA IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA STROKE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA OTHER BRAIN DISORDERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA HOSPITALS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA IMAGING DIAGNOSTIC CENTERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA AMBULATORY SURGERY CENTERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA OTHERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA DIRECT TENDER IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA RETAIL SALES IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA BRAIN MRI SCAN MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 48 NORTH AMERICA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 49 U.S.BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 50 U.S.MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI)IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 51 U.S.BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 52 U.S.BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 53 U.S.DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 54 U.S.ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 55 U.S.EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 56 U.S.PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 57 U.S.STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 58 U.S.MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 59 U.S.BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 60 U.S.BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 61 U.S.BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 62 U.S.BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 63 CANADA BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 64 CANADA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI)IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 65 CANADA BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 66 CANADA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 67 CANADA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 68 CANADA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 69 CANADA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 70 CANADA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 71 CANADA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 72 CANADA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 73 CANADA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 74 CANADA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 75 CANADA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (VOLUME)
TABLE 76 CANADA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 77 MEXICO BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 78 MEXICO MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI)IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 79 MEXICO BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 80 MEXICO BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 81 MEXICO DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 82 MEXICO ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 83 MEXICO EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 84 MEXICO PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 85 MEXICO STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 86 MEXICO MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 87 MEXICO BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 88 MEXICO BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 89 MEXICO BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (VOLUME)
TABLE 90 MEXICO BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA BRAIN MRI SCAN MARKET : SEGMENTATION
FIGURE 2 NORTH AMERICA BRAIN MRI SCAN MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA BRAIN MRI SCAN MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA BRAIN MRI SCAN MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA BRAIN MRI SCAN MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA BRAIN MRI SCAN MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA BRAIN MRI SCAN MARKET: DBMR POSITION GRID
FIGURE 8 NORTH AMERICA BRAIN MRI SCAN MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA BRAIN MRI SCAN MARKET: END USER COVERAGE GRID
FIGURE 10 NORTH AMERICA BRAIN MRI SCAN MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA BRAIN MRI SCAN MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 INCREASED PREVALENCE OF NEUOROLOGICAL DISEASES RRISE IN TECHNOLOGICAL ADVANCEMENTS IN NON-INVASIVE BRAIN SCAN MRI DEVICES AND PRODUCT APPPROVALS IS EXPECTED TO DRIVE NORTH AMERICA BRAIN MRI SCAN MARKET FROM 2022 TO 2029
FIGURE 13 SCANNER TYPE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE NORTH AMERICA BRAIN MRI SCAN MARKET FROM 2022 & 2029
FIGURE 14 TOTAL PATIENTS UNDERGOING PERIODIC HEALTH EXAMINATION USING MRI (IN MILLION0
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA BRAIN MRI SCAN MARKET
FIGURE 16 INCIDENCE OF ADULT ONSET BRAIN DISORDERS IN THE U.S. IN 2021
FIGURE 17 NORTH AMERICA BRAIN MRI SCAN MARKET: BY SCANNER TYPE, 2021
FIGURE 18 NORTH AMERICA BRAIN MRI SCAN MARKET: BY SCANNER TYPE, 2020-2029 (USD MILLION)
FIGURE 19 NORTH AMERICA BRAIN MRI SCAN MARKET: BY SCANNER TYPE, CAGR (2022-2029)
FIGURE 20 NORTH AMERICA BRAIN MRI SCAN MARKET: BY SCANNER TYPE, LIFELINE CURVE
FIGURE 21 NORTH AMERICA BRAIN MRI SCAN MARKET: BY MACHINE TYPE, 2021
FIGURE 22 NORTH AMERICA BRAIN MRI SCAN MARKET: BY MACHINE TYPE, 2020-2029 (USD MILLION)
FIGURE 23 NORTH AMERICA BRAIN MRI SCAN MARKET: BY MACHINE TYPE, CAGR (2022-2029)
FIGURE 24 NORTH AMERICA BRAIN MRI SCAN MARKET: BY MACHINE TYPE, LIFELINE CURVE
FIGURE 25 NORTH AMERICA BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, 2021
FIGURE 26 NORTH AMERICA BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, 2020-2029 (USD MILLION)
FIGURE 27 NORTH AMERICA BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, CAGR (2022-2029)
FIGURE 28 NORTH AMERICA BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, LIFELINE CURVE
FIGURE 29 NORTH AMERICA BRAIN MRI SCAN MARKET: BY END USER, 2021
FIGURE 30 NORTH AMERICA BRAIN MRI SCAN MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 31 NORTH AMERICA BRAIN MRI SCAN MARKET: BY END USER, CAGR (2022-2029)
FIGURE 32 NORTH AMERICA BRAIN MRI SCAN MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 NORTH AMERICA BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 34 NORTH AMERICA BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 35 NORTH AMERICA BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 36 NORTH AMERICA BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 37 NORTH AMERICA BRAIN MRI SCAN MARKET: SNAPSHOT (2021)
FIGURE 38 NORTH AMERICA BRAIN MRI SCAN MARKET: BY COUNTRY (2021)
FIGURE 39 NORTH AMERICA BRAIN MRI SCAN MARKET: BY REGION (2022 & 2029)
FIGURE 40 NORTH AMERICA BRAIN MRI SCAN MARKET: BY REGION (2021 & 2029)
FIGURE 41 NORTH AMERICA BRAIN MRI SCAN MARKET: BY SCANNER TYPE (2022-2029)
FIGURE 42 NORTH AMERICA BRAIN MRI SCAN MARKET: COMPANY SHARE 2021 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
